In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer
Zeyu Chen(Parker Institute for Cancer Immunotherapy), Eri Arai(University of Pennsylvania), Omar Khan(Translational Therapeutics (United States)), Zhen Zhang(University of Pennsylvania), Shin Foong Ngiow(Parker Institute for Cancer Immunotherapy), Yuan He(Johns Hopkins University), Hua Huang(Translational Therapeutics (United States)), Sasikanth Manne(Translational Therapeutics (United States)), Zhendong Cao(University of Pennsylvania), Amy E. Baxter(Translational Therapeutics (United States)), Zhangying Cai(Translational Therapeutics (United States)), Elizabeth Freilich(University of Pennsylvania), Mohammed A. Ali(Translational Therapeutics (United States)), Josephine R. Giles(Translational Therapeutics (United States)), Jennifer E. Wu(Translational Therapeutics (United States)), Allison R. Greenplate(Translational Therapeutics (United States)), Mohamed S. Abdel-Hakeem(Translational Therapeutics (United States)), Qingzhou Chen(University of Pennsylvania), Makoto Kurachi(Translational Therapeutics (United States)), Kito Nzingha(Translational Therapeutics (United States)), Viktoriya Ekshyyan(Translational Therapeutics (United States)), Divij Mathew(Translational Therapeutics (United States)), Zhuoyu Wen(University of Pennsylvania), Nancy A. Speck(University of Pennsylvania), Alexis Battle(Johns Hopkins University), Shelley L. Berger(University of Pennsylvania), E. John Wherry(Parker Institute for Cancer Immunotherapy), Junwei Shi(Translational Therapeutics (United States))
Cited by 217Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis